Favipiravir

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers

ISTH/ANRS 0409s INTEGRATE Lassa Fever Study

AGILE (Early Phase Platform Trial for COVID-19)

Efficacy of Favipiravir Against Ebola (JIKI)

Assessing Antiviral Treatments in Early Symptomatic RSV

UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF

Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen

Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection

The Prevent Severe COVID-19 (PRESECO) Study

UMIT-1 Trial Favipiravir & Ribavirin for the Treatment of CCHF

Antiviral Drugs on the Treatment of SARS-CoV-2

Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients

Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19

Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia

Control of COVID-19 Outbreaks in Long Term Care

Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever

Efficacy and Safety of JT001 (VV116) Compared With Favipiravir

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19